These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2128445)

  • 1. Oocyte donation program using a simplified hormonal regimen.
    Chang YS; Kim SH; Choi YM; Moon SY; Lee JY
    Asia Oceania J Obstet Gynaecol; 1990 Sep; 16(3):181-90. PubMed ID: 2128445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovum donation--a simplified approach.
    Serhal PF; Craft IL
    Fertil Steril; 1987 Aug; 48(2):265-9. PubMed ID: 2440730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):167-73. PubMed ID: 6217993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women.
    Jones GS; Acosta AA; Garcia JE; Bernardus RE; Rosenwaks Z
    Fertil Steril; 1985 May; 43(5):696-702. PubMed ID: 3922799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte and embryo donation in IVF programmes.
    Lütjen PJ; Leeton JF; Findlay JK
    Clin Obstet Gynaecol; 1985 Dec; 12(4):799-813. PubMed ID: 3938688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.
    Droesch K; Muasher SJ; Kreiner D; Jones GS; Acosta AA; Rosenwaks Z
    Fertil Steril; 1988 Sep; 50(3):451-6. PubMed ID: 3137100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration.
    Lejeune B; Degueldre M; Camus M; Vekemans M; Opsomer L; Leroy F
    Fertil Steril; 1986 Mar; 45(3):377-83. PubMed ID: 3949037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oocyte retrieval for in vitro fertilization.
    Diedrich K; Van der Ven H; Al-Hasani S; Werner A; Krebs D
    Ann Biol Clin (Paris); 1987; 45(3):351-7. PubMed ID: 2959179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
    Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
    Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI; Yeoman R; Aksel S
    Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI.
    Westergaard LG; Yding Andersen C; Erb K; Laursen SB; Rasmussen PE; Rex S; Teisner B
    Reprod Biomed Online; 2004 Jan; 8(1):91-8. PubMed ID: 14759294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.
    Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G
    Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment variables in relation to oocyte maturation: lessons from a clinical micromanipulation-assisted in vitro fertilization program.
    Avrech OM; Goldman GA; Rufas O; Stein A; Amit S; Yoles I; Pinkas H; Fisch B
    J Assist Reprod Genet; 1997 Jul; 14(6):337-42. PubMed ID: 9226513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval.
    Cedars MI; Surey E; Hamilton F; Lapolt P; Meldrum DR
    Fertil Steril; 1990 Apr; 53(4):627-31. PubMed ID: 2108057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization.
    Lass A; Peat D; Avery S; Brinsden P
    Hum Reprod; 1998 Nov; 13(11):3203-5. PubMed ID: 9853881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.